SCHEMBL25913071

SCHEMBL25913071

CC(C)(C)OC(=O)N(Cc1cccc(C(=N)NN)c1)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.42
GRM2 Q14416 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.38
NPC1 O15118 4/20 0.38
ALDH1A1 P00352 4/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC2 Q92769 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
MEP1B Q16820 3/20 0.36
F2 P00734 1/20 0.35
F10 P00742 1/20 0.35
AKT1 P31749 2/20 0.35
TP53 P04637 1/20 0.35
HTT P42858 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11893184 0.86 PRSS1 (0.48) SLC7A5GRM2LOXL2F2F10
SCHEMBL7385091 0.82 LOXL2 (0.55) SLC7A5LOXL2ALDH1A1RAB9ASMN1; SMN2
SCHEMBL7350811 0.81 SMN1; SMN2 (0.45) SLC7A5RAB9ASMN1; SMN2HDAC1HDAC3
SCHEMBL11891918 0.79 SLC7A5 (0.43) SLC7A5GRM2LOXL2RAB9AHDAC1
SCHEMBL19256701 0.79 SLC7A5 (0.43) SLC7A5GRM2LOXL2RAB9AHDAC1
SCHEMBL7247305 0.78 GRM2 (0.43) SLC7A5GRM2HDAC1HDAC3HDAC2
SCHEMBL8635430 0.76 AKT1 (0.44) SLC7A5GRM2HDAC1HDAC3HDAC2
SCHEMBL4398498 0.75 RIPK1 (0.53) GRM2AKT1HTTMEN1KMT2A
SCHEMBL6690431 0.75 BACE1 (0.41) GRM2NPC1RAB9ASMN1; SMN2AKT1
SCHEMBL6676782 0.75 BACE1 (0.41) GRM2HDAC1HDAC3HDAC2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190747-A1 PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS SANOFI SA (FR) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230190747-A1 PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS PTGER1, PTGIS, PTGDR SLC7A5 4500/4885GRM2 2256/4885LOXL2 1106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.